Jade Biosciences Inc.
JBIO | NASDAQ
$14.06
-$0.18 (-1.26%)
At close: Oct 30, 2026, 4:00 PM ET
$14.80
+$0.74 (+5.26%)
Pre-market:
Nov 2, 2026, 9:05 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 282K | 96K | 68K | 15K | 1K |
Gross Profit | n/a | -282K | -96K | -68K | -15K | -1K |
Operating Income | -113.54M | -74.6M | -81.41M | -53.24M | -23.02M | -8.89M |
Interest Income | 7.78M | 5.04M | 5.95M | 1.83M | 65K | n/a |
Pretax Income | -127.35M | -69.57M | -75.47M | -51.49M | -22.96M | -9.61M |
Net Income | -127.41M | -69.63M | -75.52M | -51.51M | -22.96M | -9.61M |
Selling & General & Admin | 20.42M | 21.13M | 17.09M | 14.55M | 8.02M | 948K |
Research & Development | 93.12M | 53.19M | 64.22M | 38.62M | 14.99M | 7.94M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 113.54M | 74.31M | 81.31M | 53.17M | 23.01M | 8.89M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 75K |
Selling & Marketing Expenses | 200K | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 113.54M | 74.6M | 81.41M | 53.24M | 23.02M | 8.89M |
Income Tax Expense | 58K | 55K | 56K | 25K | 3K | n/a |
Shares Outstanding (Basic) | 31.36M | 816.63K | 752.33K | 699.2K | 697.44K | 697.44K |
Shares Outstanding (Diluted) | 31.36M | 816.63K | 752.33K | 699.2K | 697.44K | 697.44K |
EPS (Basic) | -4.06 | -85.26 | -100.38 | -73.67 | -32.96 | -14 |
EPS (Diluted) | -4.06 | -85.26 | -100.38 | -73.67 | -32.96 | -14 |
EBITDA | -127.33M | -69.29M | -75.37M | -51.42M | -22.95M | -9.54M |
EBIT | -127.35M | -69.57M | -75.47M | -51.49M | -22.96M | -9.54M |
Depreciation & Amortization | 26K | 282K | 96K | 68K | 15K | 1K |
Add to Watchlist
Select watchlists to add or remove JBIO